2023年12月期 第２四半期決算短信〔ＩＦＲＳ〕（連結）

This document is the financial results report for the second quarter of the fiscal year ending December 2023 for GNI Group, Inc., covering the consolidated performance up to June 30, 2023. The report indicates a significant increase in revenue, with sales rising by 72.9% year-on-year to 14,096 million yen and operating profit increasing by 445.1% to 5,476 million yen, reflecting strong overall performance. Notably, all major subsidiaries have achieved profitability for the first time, with robust sales of the flagship product from Beijing Continent Pharmaceutical. The outlook for future performance shows no significant revisions expected.